| Income Statement |
| Total Revenue | 20.26M |
|
| Revenues (USD) | 20.26M |
| Cost of Revenue | 6.55M |
| Gross Profit | 13.71M |
| Operating Expenses | 33.13M |
| Research and Development Expense | 5.75M |
| Selling, General and Administrative Expense | 21.60M |
| Operating Income | -19.42M |
| Interest Expense | 178.00K |
| Income Tax Expense | -613.00K |
| Net Income | -19.51M |
| Net Income Common Stock | -19.51M |
| Net Income Common Stock (USD) | -19.51M |
| Consolidated Income | -19.51M |
| Earnings per Basic Share | -0.21 |
| Earnings per Basic Share (USD) | -0.21 |
| Earnings per Diluted Share | -0.21 |
| Earning Before Interest & Taxes (EBIT) | -19.94M |
| Earning Before Interest & Taxes (USD) | -19.94M |
| Weighted Average Shares | 92.90M |
| Weighted Average Shares Diluted | 92.90M |
| Balance Sheet |
| Cash and Equivalents | 15.37M |
| Cash and Equivalents (USD) | 15.37M |
| Trade and Non-Trade Receivables | 26.72M |
| Current Assets | 50.45M |
| Property, Plant & Equipment Net | 9.14M |
| Total Assets | 155.20M |
| Debt Current | 45.39M |
| Total Debt | 45.39M |
| Current Liabilities | 96.26M |
| Total Liabilities | 106.20M |
| Accumulated Retained Earnings (Deficit) | -598.52M |
| Accumulated Other Comprehensive Income | 713.00K |
| Shareholders Equity | 49.00M |
| Shareholders Equity (USD) | 49.00M |
| Assets Non-Current | 104.75M |
| Total Debt (USD) | 45.39M |
| Deferred Revenue | 13.19M |
| Goodwill and Intangible Assets | 88.04M |
| Liabilities Non-Current | 9.94M |
| Trade and Non-Trade Payables | 12.95M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 5.86M |
| Net Cash Flow from Financing | -486.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -12.34M |
| Capital Expenditure | -534.00K |
| Issuance (Purchase) of Equity Shares | 162.00K |
| Net Cash Flow from Investing | -534.00K |
| Net Cash Flow from Operations | -11.49M |
| Effect of Exchange Rate Changes on Cash | 170.00K |
| Share Based Compensation | 1.19M |